Ac Immune Sa
Clinical trials sponsored by Ac Immune Sa, explained in plain language.
-
New shot aims to slow Alzheimer's in people with down syndrome
Disease control Recruiting nowThis study tests an experimental treatment called ACI-24.060 in people with early Alzheimer's disease and in adults with Down syndrome who do not have dementia. The goal is to see if it is safe and can help the immune system clear harmful amyloid plaques from the brain. About 304…
Phase: PHASE1, PHASE2 • Sponsor: AC Immune SA • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New PET tracer aims to spot Parkinson's protein in the brain
Diagnosis Recruiting nowThis early-phase study tests a new radioactive tracer called [18F]ACI-15916, designed to detect clumps of α-synuclein protein in the brain using PET scans. These protein deposits are linked to Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies. The trial …
Phase: EARLY_PHASE1 • Sponsor: AC Immune SA • Aim: Diagnosis
Last updated Jun 23, 2026 22:04 UTC
-
New brain drug ACI-19764 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage trial is testing a new drug called ACI-19764 in 78 healthy adults to see if it is safe and how the body handles it. The drug targets a protein in the brain linked to inflammation. Participants will receive either the drug or a placebo, and researchers will monito…
Phase: PHASE1 • Sponsor: AC Immune SA • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:59 UTC